Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer Patients
100%
Clinical Sensitivity
100%
Clinical Specificities
100%
Prostate Cancer
80%
Healthy Controls
40%
Prostate Cancer Screening
40%
Ct Value
40%
Assay Reproducibility
40%
Diagnostic Tool
20%
United States
20%
Gene Expression
20%
No Significant Difference
20%
Patient Outcomes
20%
Quantitative PCR
20%
High Specificity
20%
Receiver Operating Characteristic Analysis
20%
Blood Samples
20%
Complementary DNA (cDNA)
20%
High Sensitivity
20%
Incidence Rate
20%
Diverse Populations
20%
Blood-based
20%
Treatment Setting
20%
Area under the Receiver Operating Characteristic Curve
20%
Skin Cancer
20%
Validation Studies
20%
Cancer Monitoring
20%
Residual Disease
20%
False Positive Rate
20%
Early Prostate Cancer
20%
Untreated Patients
20%
Overtreatment
20%
Assay Specificity
20%
RNA Isolation
20%
Noninvasive Diagnostic Method
20%
Unmet
20%
Assay Sensitivity
20%
Gene Algorithm
20%
Binary Output
20%
Assay Comparison
20%
PSA Testing
20%
Analytical Reproducibility
20%
Assay Robustness
20%
Biochemistry, Genetics and Molecular Biology
Real-Time Polymerase Chain Reaction
100%
Gene Expression
100%
Prospective Study
100%
RNA Isolation
100%
Biochemical Screening
100%
Medicine and Dentistry
Prostate Cancer
100%
Sensitivity and Specificity
100%
Reproducibility
30%
Cancer Diagnosis
20%
Malignant Neoplasm
10%
Prospective Study
10%
Real-Time Polymerase Chain Reaction
10%
Gene Expression
10%
Complementary DNA
10%
False Positive Result
10%
Skin Cancer
10%
Prostate Cancer Diagnosis
10%
Minimal Residual Disease
10%
Cancer Epidemiology
10%
Non-Invasive Diagnostics
10%
Overdiagnosis
10%
Immunology and Microbiology
Gene Expression
100%
Real-Time Polymerase Chain Reaction
100%
RNA Isolation
100%